Jul 2026· IEEE Transactions on Computational Biology and Bioinformatics· Vol 23, pp. 2014-2025· 0 citations· 54 references
Medicine
Abstract
Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder that demands more comprehensive and precise modeling to unravel its complex pathological mechanisms and multidimensional brain network abnormalities. However, current brain network analysis approaches often suffer from limitations such as single-modal data processing and shallow fusion strategies, which hinder their ability to capture the multi-scale connectivity patterns associated with AD effectively. To alleviate these limitations, a novel multi-modal fusion framework is proposed in this paper, namely a cross-modal self-distillation graph convolutional network (CSD-GCN). The framework can deeply integrate fMRI and DTI data to facilitate the systematic extraction of hierarchical features from multimodal brain networks. The architecture of CSD-GCN comprises three progressive layers: edge-to-edge (E2E), edge-to-node (E2N), and node-to-graph (N2G). These layers are designed to perform multi-scale feature extraction, capturing neurodegenerative patterns ranging from local connection strengths to global topological structures. Moreover, the model incorporates a cross-modal self-knowledge distillation strategy and a cross-attention mechanism to enhance inter-modal feature alignment and fusion. These components collectively improve the generalization ability and discriminative capability of the learned representations. Experimental evaluations show that CSD-GCN outperforms existing methods in binary and ternary classification tasks for AD, with ablation studies confirming the individual effect of each component within the proposed framework.
GraM-Diff is proposed, a unified classifier-guided Graph-Mamba diffusion framework for EEG synthesis that embeds Graph Convolutional Networks within a diffusion U-Net to model inter-electrode connectivity and Bidirectional Mamba state-space blocks for linear-complexity long-range temporal modeling.
M. Tanveer, A. Rana, Sanskriti Jain et al.· 0 citations
Separating Alzheimer's Disease (AD), Parkinson's Disease (PD), and Healthy Controls (HC) using structural MRI remains challenging because disease signatures overlap and model performance can be strongly affected by data partitioning. We present HybridDualPathNet, a hybrid architecture combining EfficientNetV2-S for loc...
Resting-state functional magnetic resonance imaging (rs-fMRI) serves as a widely used non-invasive brain imaging tool for investigating neurological disorders through functional brain networks (FBN) modeling among brain regions of interest (ROIs). Deep learning frameworks, notably graph neural networks and Transformers...
Li-Na Zhou, Yue-Ying Zhou, Yun-Ling Ma et al.· IEEE journal of biomedical a...· 0 citations
An innovative method for multi-view graph clustering named the graph convolution Transformer network with self-distillation (MvCConvFormer), which applies the Transformer architecture to effectively fuse the structural information of the optimal adjacency matrix and the node representations learned by the pre-training...
Despite advances in magnetic resonance imaging (MRI) technologies and the arrival of deep learning approaches, early and accurate diagnosis of Alzheimer's disease (AD) is still a difficult task, as subtle changes in the neuroanatomical structure of the brain, inter-subject variability, and the lack of the ability to in...
Ramya C. N., Keshavamurthy· International Research Journ...· 0 citations
Cross-modal brain networks characterize the complex connections between different brain regions from both functional and structural perspectives, which is of significant importance for brain network analysis and the diagnosis of brain diseases. However, existing methods have failed to fully exploit the complementary in...
Jing-Xi Feng, He-Ming Xu, Rundong Xue et al.· Proceedings of the Thirty-Fi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.